Revvity IncRVTY
Price$149.06Intrinsic value$74.8850% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $74.88median of 6 methods · middle span $42-$112based on filings through 5 Jul 2026
Market Price $149.06Price as of 1 Oct 2026
Margin of Safety -49.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 11.7% (near-term consensus, capped) · years 2–5: 6.1%/yr (balance of the path).7.2% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 65.5%Yr 74.9%Yr 84.2%Yr 93.6%Yr 103.0%
6.1% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (6/7y) (limited history)-0.1%
Discount rate (cost of equity) 9.7%
Volatility vs market (adjusted beta)1.05

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetRevvity IncRVTYHealth Care
Valuation
P/E71.7×
P/S5.6×
P/B2.2×
EV / Revenue6.4×
EV / EBITDA15.7×
Profitability
Gross margin54.8%
Operating margin12.5%
Net margin8.2%
FCF margin19.2%
Returns
ROE3.3%
ROA2.0%
ROIC2.5%
Growth
Revenue growth (YoY)5.7%
5-yr fwd EPS growth8.6%
Financial strength
Debt / Equity0.44×
Current ratio1.80×
Altman Z-Score3.2
Interest coverage—
Dividend yield0.1%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.